Abstract

BackgroundThe anticancer properties of cisplatin and palladium(II) complexes stem from the ability of the cis-MCl2 fragment to bind to DNA bases. However, cisplatin also interacts with non-cancer cells, mainly through bonding molecules containing -SH groups, resulting in nephrotoxicity. This has aroused interest in the design of palladium(II) complexes of improved activity and lower toxicity. The reaction of DNA bases with palladium(II) complexes with chelating N,N/donors of the cis-MCl2 configuration constitutes a model system that may help explore the mechanism of cisplatin's anticancer activity. Heterocyclic compounds are found widely in nature and are essential to many biochemical processes. Amongst these naturally occurring compounds, the most thoroughly studied is that of pyrimidine. This was one of the factors that encouraged this study into the kinetics and mechanism of the interaction of 2-aminopyrimidine (2-NH2-Pym) with dichloro-{1-alkyl-2-(α-naphthylazo)imidazole}palladium(II) [Pd(α-NaiR)Cl2, 1] and dichloro-{1-alkyl-2-(β-naphthylazo)imidazole}palladium(II) [Pd(β-NaiR)Cl2, 2] complexes where the alkyl R = Me (a), Et (b), or Bz (c).Results2-NH2-Pym reacts with 1a, 1b, and 1c to yield [{1-alkyl-2-(α-naphthylazo)imidazole}bis(2-aminopyrimidine)]palladium(II) (3a, 3b, 3c) dichloride and with 2a, 2b, and 2c to yield [{1-alkyl-2-(β-naphthylazo)imidazole}bis(2-aminopyrimidine)]palladium(II) (4a, 4b, 4c) dichloride in an acetonitrile (MeCN) medium. The products were characterized using spectroscopic techniques (FT-IR, UV-Vis, NMR). The ligand substitution reactions follow second order kinetics – first order dependence on the concentration of the Pd(II) complex and 2-NH2-Pym. Addition of LiCl to the reaction does not influence its rate. The thermodynamic parameters (standard enthalpy of activation, Δ‡H° and standard entropy of activation, Δ‡S°) were determined from variable temperature kinetic studies. The magnitude of the second order rate constant, k2, at 298 K, was shown to increase thus: b <a <c as well as 1 <2.ConclusionThe kinetics of the reaction between Pd(II) complexes (1 and 2) and 2-NH2-Pym were examined spectrophotometrically at 530 nm in MeCN under pseudo-first-order conditions. The reaction rate is largely influenced by the π-acidity of the chelating ligand, with substitution in the naphthyl azoimidazole backbone influencing the rate of the substitution process. The activation parameters, Δ‡H° and Δ‡S°, were determined and support the kinetic rate data.

Highlights

  • The anticancer properties of cisplatin and palladium(II) complexes stem from the ability of the cis-MCl2 fragment to bind to DNA bases

  • The reaction of DNA bases with Pt(II) complexes with chelating N,N/donors of the cis-MCl2 configuration constitutes a model system that may permit the exploration of the mechanism of cisplatin's anticancer activity

  • In this study we present the kinetic and mechanistic studies of the reaction of 2-NH2Pym with 1 and 2

Read more

Summary

Introduction

The anticancer properties of cisplatin and palladium(II) complexes stem from the ability of the cis-MCl2 fragment to bind to DNA bases. Cisplatin interacts with noncancer cells, mainly through bonding molecules containing -SH groups, resulting in nephrotoxicity This has aroused interest in the design of palladium(II) complexes of improved activity and lower toxicity. The reaction of DNA bases with palladium(II) complexes with chelating N,N/donors of the cis-MCl2 configuration constitutes a model system that may help explore the mechanism of cisplatin's anticancer activity. The anticancer properties of cis-Pt(NH3)2Cl2 or cisplatin [1,2,3,4,5,6,7,8,9] have given impetus to research in the field of platinum chemistry This anticancer activity stems from the binding of the cis-PtCl2 fragment with DNA bases. The reaction of DNA bases with Pt(II) complexes with chelating N,N/donors of the cis-MCl2 configuration constitutes a model system that may permit the exploration of the mechanism of cisplatin's anticancer activity. The kinetics and mechanism of the substitution reactions involving Pd(II) complexes of 1-alkyl-2-(arylazo)imidazoles (i) (Figure 1) with adenine [28], cytosine [29], 2-mercapto-pyridine [30], 2amino-pyrimidine [31], picolinic acid [32,33], and 8hydroxy quinoline [34,35] have been reported

Objectives
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call